J.Molner AS (OTSE:MOLNR) Debt-to-Revenue : 3.14 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

J.Molner AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €0.27 Mil. J.Molner AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €1.91 Mil. J.Molner AS's annualized Revenue for the quarter that ended in Dec. 2023 was €0.69 Mil. J.Molner AS's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 3.14.

J.Molner AS Debt-to-Revenue Historical Data

The historical data trend for J.Molner AS's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Debt-to-Revenue Chart

J.Molner AS Annual Data

Trend

Dec21

Dec22

Dec23

Debt-to-Revenue

1.21

6.75

3.53

J.Molner AS Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Revenue	N/A	1.24	23.14	2.23	3.14

Competitive Comparison of J.Molner AS's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, J.Molner AS's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

J.Molner AS's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, J.Molner AS's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where J.Molner AS's Debt-to-Revenue falls into.

J.Molner AS Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

J.Molner AS's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.268	+	1.911)	/	0.618
	=	3.53

J.Molner AS's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.268	+	1.911)	/	0.694
	=	3.14

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.

J.Molner AS Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of J.Molner AS's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

J.Molner AS (OTSE:MOLNR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Debt-to-Revenue

Traded in Other Exchanges

N/A

Address

Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618

Website

https://www.jmolner.com

J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines